JPMorgan Chase & Co’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$494K Buy
60,662
+7,943
+15% +$64.7K ﹤0.01% 4077
2025
Q1
$414K Buy
52,719
+9,368
+22% +$73.5K ﹤0.01% 4116
2024
Q4
$645K Sell
43,351
-334
-0.8% -$4.97K ﹤0.01% 4039
2024
Q3
$668K Buy
43,685
+1,117
+3% +$17.1K ﹤0.01% 3865
2024
Q2
$648K Buy
42,568
+2,342
+6% +$35.7K ﹤0.01% 3726
2024
Q1
$759K Sell
40,226
-39,662
-50% -$749K ﹤0.01% 3722
2023
Q4
$1.53M Buy
79,888
+1,569
+2% +$30K ﹤0.01% 3295
2023
Q3
$1.41M Sell
78,319
-1,481
-2% -$26.6K ﹤0.01% 3220
2023
Q2
$1.62M Sell
79,800
-460,195
-85% -$9.35M ﹤0.01% 3155
2023
Q1
$9.85M Buy
539,995
+25,084
+5% +$458K ﹤0.01% 2018
2022
Q4
$10.6M Buy
514,911
+11,178
+2% +$231K ﹤0.01% 1867
2022
Q3
$13.2M Sell
503,733
-13,459
-3% -$352K ﹤0.01% 1690
2022
Q2
$13.1M Buy
517,192
+81,399
+19% +$2.06M ﹤0.01% 1707
2022
Q1
$13.8M Buy
435,793
+167,381
+62% +$5.28M ﹤0.01% 1806
2021
Q4
$10.9M Sell
268,412
-947
-0.4% -$38.3K ﹤0.01% 2027
2021
Q3
$9.39M Sell
269,359
-4,374
-2% -$153K ﹤0.01% 2100
2021
Q2
$7.52M Sell
273,733
-104,290
-28% -$2.86M ﹤0.01% 2358
2021
Q1
$10.6M Sell
378,023
-119,119
-24% -$3.34M ﹤0.01% 2087
2020
Q4
$12.9M Buy
497,142
+57,284
+13% +$1.49M ﹤0.01% 1750
2020
Q3
$7.66M Buy
439,858
+28,809
+7% +$502K ﹤0.01% 1950
2020
Q2
$10.2M Buy
411,049
+22,985
+6% +$569K ﹤0.01% 1685
2020
Q1
$5.39M Sell
388,064
-80,300
-17% -$1.11M ﹤0.01% 1949
2019
Q4
$4.73M Sell
468,364
-43,000
-8% -$434K ﹤0.01% 2199
2019
Q3
$4.65M Sell
511,364
-3,898
-0.8% -$35.5K ﹤0.01% 2234
2019
Q2
$3.98M Buy
515,262
+26,709
+5% +$206K ﹤0.01% 2268
2019
Q1
$6.1M Sell
488,553
-4,260
-0.9% -$53.2K ﹤0.01% 2001
2018
Q4
$5.31M Buy
492,813
+20,741
+4% +$223K ﹤0.01% 2067
2018
Q3
$6.58M Buy
472,072
+215,534
+84% +$3M ﹤0.01% 2079
2018
Q2
$3.14M Buy
256,538
+255,438
+23,222% +$3.13M ﹤0.01% 2534
2018
Q1
$17K Buy
+1,100
New +$17K ﹤0.01% 4437